DDO001B
Total Payments
$10,630
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $10,630 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,630 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RETINA VALIDATION TRIAL | Novartis Pharmaceuticals Corporation | $10,630 | 0 |
Top Doctors Receiving Payments for DDO001B
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Baltimore, MD | $10,630 | 2 |
Ad
Manufacturing Companies
Product Information
- Type Product
- Total Payments $10,630
- Total Doctors 0
- Transactions 2
About DDO001B
DDO001B is a product associated with $10,630 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.
Payment data is available from 2020 to 2020. In 2020, $10,630 was paid across 2 transactions to 0 doctors.
The most common payment nature for DDO001B is "Unspecified" ($10,630, 100.0% of total).
DDO001B is associated with 1 research study, including "RETINA VALIDATION TRIAL" ($10,630).